Michael Levy

669 total citations
16 papers, 546 citations indexed

About

Michael Levy is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Michael Levy has authored 16 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 11 papers in Hepatology and 4 papers in Infectious Diseases. Recurrent topics in Michael Levy's work include Hepatitis C virus research (11 papers), Hepatitis B Virus Studies (7 papers) and HIV, Drug Use, Sexual Risk (5 papers). Michael Levy is often cited by papers focused on Hepatitis C virus research (11 papers), Hepatitis B Virus Studies (7 papers) and HIV, Drug Use, Sexual Risk (5 papers). Michael Levy collaborates with scholars based in Australia, United States and Canada. Michael Levy's co-authors include Paul Haber, Andrew R. Lloyd, John Kaldor, William D. Rawlinson, Kate Dolan, Tony Butler, Gregory J. Dore, Suzy Teutsch, Nicolas Scheuer and Rosemary Ffrench and has published in prestigious journals such as The Journal of Infectious Diseases, BMC Public Health and Vaccine.

In The Last Decade

Michael Levy

16 papers receiving 522 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Levy Australia	11	406	330	108	71	66	16	546
Sheila Cameron United Kingdom	13	580 1.4×	452 1.4×	155 1.4×	50 0.7×	54 0.8×	21	676
Tamara McDonald United Kingdom	7	547 1.3×	348 1.1×	213 2.0×	91 1.3×	48 0.7×	8	619
D. Goldberg United Kingdom	12	285 0.7×	179 0.5×	97 0.9×	48 0.7×	61 0.9×	30	394
Silva P. Kouyoumjian Qatar	16	519 1.3×	416 1.3×	131 1.2×	40 0.6×	64 1.0×	24	663
Carlos J Conde-González Mexico	14	293 0.7×	160 0.5×	83 0.8×	98 1.4×	78 1.2×	37	447
Ricardo Andrade Carmo Brazil	14	263 0.6×	208 0.6×	173 1.6×	23 0.3×	71 1.1×	33	503
Henry H. Cagle United States	12	613 1.5×	481 1.5×	87 0.8×	49 0.7×	70 1.1×	27	696
Sofia Bartlett Canada	15	519 1.3×	447 1.4×	161 1.5×	25 0.4×	60 0.9×	58	731
Tullio Prestileo Italy	14	452 1.1×	294 0.9×	387 3.6×	74 1.0×	41 0.6×	32	730
Stacey Trooskin United States	16	527 1.3×	490 1.5×	217 2.0×	41 0.6×	120 1.8×	30	725

Countries citing papers authored by Michael Levy

Since Specialization

Citations

This map shows the geographic impact of Michael Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Levy more than expected).

Fields of papers citing papers by Michael Levy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Levy. The network helps show where Michael Levy may publish in the future.

Co-authorship network of co-authors of Michael Levy

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Levy. A scholar is included among the top collaborators of Michael Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Levy. Michael Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Simpson, Paul, John Kaldor, Alun Richards, et al.. (2019). Trends in hepatitis B prevalence and associated risk factors among Indigenous and non‐Indigenous prison entrants in Australia, 2004 to 2013. Australian and New Zealand Journal of Public Health. 43(3). 236–240. 5 indexed citations

Levy, Michael, et al.. (2017). Why is there still hepatitis C transmission in Australian prisons? A case report. Harm Reduction Journal. 14(1). 75–75. 4 indexed citations

Reekie, Joanne, et al.. (2014). Trends in HIV, hepatitis B and hepatitis C prevalence among Australian prisoners ‐ 2004, 2007, 2010. The Medical Journal of Australia. 200(5). 277–280. 52 indexed citations

Dolan, Kate, Suzy Teutsch, Nicolas Scheuer, et al.. (2010). Incidence and risk for acute hepatitis C infection during imprisonment in Australia. European Journal of Epidemiology. 25(2). 143–148. 72 indexed citations

Haber, Paul, et al.. (2010). Establishment of a successful assessment and treatment service for Australian prison inmates with chronic hepatitis C. The Medical Journal of Australia. 192(9). 496–500. 40 indexed citations

Wallace, Jack, et al.. (2010). Regulating Hepatitis C: Rights and Duties Preventing Hepatitis C Transmission in Australian Adult Correctional Settings. 3 indexed citations

Teutsch, Suzy, Fabio Luciani, Nicolas Scheuer, et al.. (2010). Incidence of primary hepatitis C infection and risk factors for transmission in an Australian prisoner cohort. BMC Public Health. 10(1). 70 indexed citations

Butler, Tony, et al.. (2007). The 2004 Australian prison entrants' blood‐borne virus and risk behaviour survey. Australian and New Zealand Journal of Public Health. 31(1). 44–50. 60 indexed citations

Levy, Michael. (2006). Palliative Care. Journal of the National Comprehensive Cancer Network. 4(8). 776–776. 25 indexed citations

10.

Thein, Hla‐Hla, Tony Butler, Murray Krahn, et al.. (2006). The Effect of Hepatitis C Virus Infection on Health-Related Quality of Life in Prisoners. Journal of Urban Health. 83(2). 275–288. 22 indexed citations

11.

Young, Lorraine C, et al.. (2004). Summer outbreak of respiratory disease in an Australian prison due to an influenza A/Fujian/411/2002(H3N2)-like virus. Epidemiology and Infection. 133(1). 107–112. 36 indexed citations

12.

Post, Jeffrey J., Yong Pan, Anthony Freeman, et al.. (2004). Clearance of Hepatitis C Viremia Associated with Cellular Immunity in the Absence of Seroconversion in the Hepatitis C Incidence and Transmission in Prisons Study Cohort. The Journal of Infectious Diseases. 189(10). 1846–1855. 119 indexed citations

13.

Awofeso, Niyi, et al.. (2001). Response to HBV vaccine in relation to vaccine dose and anti-HCV positivity: a New South Wales correctional facilities’ study. Vaccine. 19(30). 4245–4248. 13 indexed citations

14.

Levy, Michael, et al.. (1995). Tuberculosis screening in inmates and staff of a NSW jail. New South Wales Public Health Bulletin. 6(3). 19–19. 2 indexed citations

15.

Levy, Michael, et al.. (1995). Inhibition of HIV-1-induced syncytia formation and infectivity by lipophosphoglycan from Leishmania.. PubMed. 10(5). 496–505. 17 indexed citations

16.

Levy, Michael & Ε. Frederick Wheelock. (1976). The role of macrophages in suppression of established Friend virus leukemia.. PubMed. 20(3). 243–54. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact